Genmab A (GMAB) Return on Equity: 2020-2021
- Genmab A's Return on Equity fell 2.00% to 0.00% in Q2 2021 from the same period last year, while for Jun 2021 it was 0.00%, marking a year-over-year decrease of 2.00%. This contributed to the annual value of 0.28% for FY2020, which is 10.00% up from last year.
- As of Q2 2021, Genmab A's Return on Equity stood at 0.00%, which was up 100.00% from -0.01% recorded in Q4 2020.
- Over the past 5 years, Genmab A's Return on Equity peaked at 0.02% during Q2 2020, and registered a low of -0.01% during Q4 2020.
- Its 2-year average for Return on Equity is 0.00%, with a median of 0.00% in 2021.
- Data for Genmab A's Return on Equity shows a maximum YoY declined of 2bps (in 2021) over the last 5 years.
- Quarterly analysis of 2 years shows Genmab A's Return on Equity stood at -0.01% in 2020, then dropped by 2bps to 0.00% in 2021.
- Its Return on Equity stands at 0.00% for Q2 2021, versus -0.01% for Q4 2020 and 0.02% for Q2 2020.
